Andrzej S. Królewski

23.0k total citations · 7 hit papers
190 papers, 15.7k citations indexed

About

Andrzej S. Królewski is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Andrzej S. Królewski has authored 190 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Nephrology, 60 papers in Endocrinology, Diabetes and Metabolism and 54 papers in Genetics. Recurrent topics in Andrzej S. Królewski's work include Chronic Kidney Disease and Diabetes (71 papers), Pancreatic function and diabetes (43 papers) and Diabetes and associated disorders (32 papers). Andrzej S. Królewski is often cited by papers focused on Chronic Kidney Disease and Diabetes (71 papers), Pancreatic function and diabetes (43 papers) and Diabetes and associated disorders (32 papers). Andrzej S. Królewski collaborates with scholars based in United States, Poland and Japan. Andrzej S. Królewski's co-authors include James H. Warram, C. Ronald Kahn, Blaise C. Martin, Linda Ficociello, Bruce A. Perkins, Monika A. Niewczas, A.Richard Christlieb, Adam M. Smiles, Alessandro Doria and Jan Skupień and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Andrzej S. Królewski

186 papers receiving 15.1k citations

Hit Papers

Role of glucose and insulin resistance in development of ... 1985 2026 1998 2012 1992 1991 1985 2003 1987 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study
    1992 971 citations Blaise C. Martin, James H. Warram et al. The Lancet profile →
  2. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women
    1991 923 citations Andrzej S. Królewski et al. The Lancet profile →
  3. The changing natural history of nephropathy in type I Diabetes
    1985 620 citations Andrzej S. Królewski, James H. Warram et al. profile →
  4. Regression of Microalbuminuria in Type 1 Diabetes
    2003 557 citations Bruce A. Perkins, Linda Ficociello et al. profile →
  5. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus
    1987 491 citations Andrzej S. Królewski, Edward Kosinski et al. profile →
  6. Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
    2012 367 citations Monika A. Niewczas, Jan Skupień et al. Journal of the American Society of Nephrology profile →
  7. Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes
    2014 327 citations Adam M. Smiles, Andrzej S. Królewski et al. Journal of the American Society of Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrzej S. Królewski United States 63 5.8k 5.3k 3.2k 3.2k 3.1k 190 15.7k
James H. Warram United States 68 6.4k 1.1× 5.2k 1.0× 3.8k 1.2× 3.5k 1.1× 3.5k 1.1× 190 17.3k
Barry I. Freedman United States 65 3.2k 0.5× 6.2k 1.2× 3.0k 1.0× 1.8k 0.6× 3.3k 1.0× 420 16.3k
Carol Forsblom Finland 60 5.2k 0.9× 2.3k 0.4× 2.9k 0.9× 2.5k 0.8× 2.4k 0.8× 276 12.2k
Michel Marre France 66 8.7k 1.5× 2.3k 0.4× 2.2k 0.7× 3.3k 1.1× 3.9k 1.3× 423 17.2k
Masakazu Haneda Japan 67 5.4k 0.9× 3.5k 0.7× 1.1k 0.3× 2.7k 0.9× 4.8k 1.5× 292 16.1k
Giancarlo Viberti United Kingdom 62 6.6k 1.1× 4.0k 0.8× 1.0k 0.3× 2.1k 0.7× 3.7k 1.2× 190 13.7k
Janet B. McGill United States 64 9.1k 1.6× 2.2k 0.4× 1.9k 0.6× 3.4k 1.1× 2.4k 0.8× 236 16.2k
H. Keen United Kingdom 64 9.1k 1.6× 3.1k 0.6× 2.2k 0.7× 2.8k 0.9× 2.0k 0.6× 259 16.4k
K. Borch‐Johnsen Denmark 59 5.5k 0.9× 2.2k 0.4× 1.8k 0.6× 1.7k 0.6× 1.8k 0.6× 176 12.5k
Hans‐Henrik Parving Denmark 71 8.9k 1.5× 7.4k 1.4× 1.0k 0.3× 2.2k 0.7× 2.8k 0.9× 232 20.8k

Countries citing papers authored by Andrzej S. Królewski

Since Specialization
Citations

This map shows the geographic impact of Andrzej S. Królewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej S. Królewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej S. Królewski more than expected).

Fields of papers citing papers by Andrzej S. Królewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej S. Królewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej S. Królewski. The network helps show where Andrzej S. Królewski may publish in the future.

Co-authorship network of co-authors of Andrzej S. Królewski

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej S. Królewski. A scholar is included among the top collaborators of Andrzej S. Królewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej S. Królewski. Andrzej S. Królewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haukka, Jani K., Erkka Valo, Anna Syreeni, et al.. (2024). Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease. Diabetologia. 67(11). 2494–2506.
2.
Satake, Eiichiro, Parker C. Wilson, Bozena Krolewski, et al.. (2024). Circulating proteins linked to apoptosis processes and fast development of end-stage kidney disease in diabetes. JCI Insight. 9(20). 3 indexed citations
3.
Satake, Eiichiro, Bozena Krolewski, Hiroki Kobayashi, et al.. (2024). Preanalytical considerations in quantifying circulating miRNAs that predict end-stage kidney disease in diabetes. JCI Insight. 9(12). 2 indexed citations
4.
Chen, Zhuo, Eiichiro Satake, Marcus G. Pezzolesi, et al.. (2024). Integrated analysis of blood DNA methylation, genetic variants, circulating proteins, microRNAs, and kidney failure in type 1 diabetes. Science Translational Medicine. 16(748). eadj3385–eadj3385. 8 indexed citations
5.
Kobayashi, Hiroki, Helen C. Looker, Zaipul I. Md Dom, et al.. (2024). Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins. Clinical Journal of the American Society of Nephrology. 20(2). 186–196.
6.
Dom, Zaipul I. Md, Eiichiro Satake, Jan Skupień, et al.. (2021). Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes. Science Translational Medicine. 13(600). 20 indexed citations
7.
Satake, Eiichiro, Marcus G. Pezzolesi, Zaipul I. Md Dom, et al.. (2018). Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes. Diabetes. 67(5). 1013–1023. 75 indexed citations
8.
Skupień, Jan, James H. Warram, Adam M. Smiles, et al.. (2014). Improved Glycemic Control and Risk of ESRD in Patients with Type 1 Diabetes and Proteinuria. Journal of the American Society of Nephrology. 25(12). 2916–2925. 36 indexed citations
9.
Królewski, Andrzej S., James H. Warram, Carol Forsblom, et al.. (2012). Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes. Diabetes Care. 35(11). 2311–2316. 54 indexed citations
10.
Liew, Chong Wee, Jacek Bocheński, Dan Kawamori, et al.. (2010). The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse β cells. Journal of Clinical Investigation. 120(8). 2876–2888. 104 indexed citations
11.
Ficociello, Linda, Elizabeth Rosolowsky, Monika A. Niewczas, et al.. (2010). High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes. Diabetes Care. 33(6). 1337–1343. 177 indexed citations
12.
Merchant, Michael L., Bruce A. Perkins, Grzegorz M. Boratyn, et al.. (2009). Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria. Journal of the American Society of Nephrology. 20(9). 2065–2074. 110 indexed citations
13.
Mueller, Patricia W., John Rogus, Patricia A. Cleary, et al.. (2006). Genetics of Kidneys in Diabetes (GoKinD) Study. Journal of the American Society of Nephrology. 17(7). 1782–1790. 94 indexed citations
14.
Placha, Grzegorz, Krzysztof Wanic, Maciej T. Małecki, et al.. (2006). New Polymorphism of ENPP1 (PC-1) Is Associated With Increased Risk of Type 2 Diabetes Among Obese. 3 indexed citations
15.
Perkins, Bruce A. & Andrzej S. Królewski. (2005). Early nephropathy in type 1 diabetes: A new perspective on who will and who will not progress. Current Diabetes Reports. 5(6). 455–463. 48 indexed citations
16.
Kim, Sung‐Hoon, James H. Warram, Andrzej S. Królewski, & Alessandro Doria. (2001). Mutation Screening of the Neurogenin-3 Gene in Autosomal Dominant Diabetes1. The Journal of Clinical Endocrinology & Metabolism. 86(5). 2320–2322. 6 indexed citations
17.
Zanchi, Anne, Dariusz Moczulski, L Hanna, et al.. (2000). Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney International. 57(2). 405–413. 13 indexed citations
18.
Królewski, Andrzej S., James H. Warram, & Maria Beatriz Sayeg Freire. (1996). EPIDEMIOLOGY OF LATE DIABETIC COMPLICATIONS. Endocrinology and Metabolism Clinics of North America. 25(2). 217–242. 56 indexed citations
19.
Martin, Blaise C., James H. Warram, Andrzej S. Królewski, et al.. (1992). Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. The Lancet. 340(8825). 925–929. 971 indexed citations breakdown →
20.
Valsania, Paola, et al.. (1991). Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus. American Heart Journal. 122(3). 695–700. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James H. Warram Breakdown of academic impact, for papers by Barry I. Freedman Breakdown of academic impact, for papers by Carol Forsblom Breakdown of academic impact, for papers by Michel Marre Breakdown of academic impact, for papers by Masakazu Haneda Breakdown of academic impact, for papers by Giancarlo Viberti Breakdown of academic impact, for papers by Janet B. McGill Breakdown of academic impact, for papers by H. Keen Breakdown of academic impact, for papers by K. Borch‐Johnsen Breakdown of academic impact, for papers by Hans‐Henrik Parving
Rankless by CCL
2026